Sirdás sisdollui
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Giella
Buot deaivamat
Bajilčálus
Dahkki
Fáddá
Hildobáiki
ISBN/ISSN
Fáddágilkor
Viečča
Aiddostahtton
N-terminal pro-B-type natriure...
Čujuhandieđut
Deakstadieđáhus
Sádde šleađgaboasttain
Čálit
Doalvvo čujuhusa
Doalvun: RefWorks
Doalvun: EndNoteWeb
Doalvun: EndNote
Bissovaš liŋka
N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study
Bibliográfalaš dieđut
Váldodahkkit:
Emberson, J
,
Armitage, J
,
Ng, L
,
Bowman, L
,
Parish, S
,
Collins, R
,
Collaborati, H
Materiálatiipa:
Conference item
Almmustuhtton:
2005
Oažžasuvvandieđut
Govvádus
Geahča maid
Bargiidšearbma
Geahča maid
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
Dahkki: Emberson, JR, et al.
Almmustuhtton: (2007)
N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study
Dahkki: Emberson, J, et al.
Almmustuhtton: (2005)
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial
Dahkki: Collins, R, et al.
Almmustuhtton: (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
Dahkki: Heart Protection Study Collaborative Group
Almmustuhtton: (2002)
MRC/BHF Heart Protection Study - Reply
Dahkki: Collins, R, et al.
Almmustuhtton: (2002)